Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Apollo gets $11.5m for surgical tools:

This article was originally published in Clinica

Executive Summary

Apollo Endosurgery (Austin, Texas) is accelerating the development of its natural orifice surgical products after raising $11.5m in a series A financing round. The round, which saw contributions from PTV Sciences, HIG Ventures and individual investors, allows Apollo to conduct US human trials for its NOTES (the acronym for endoluminal and translumenal surgical procedures) system. The technology allows surgeons to access the peritoneal cavity for both diagnostic and surgical treatments. According to Apollo, its devices carry out endoluminal and translumenal procedures with less pain, less sedation, and with a faster recovery time.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT049962

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel